Skip to content
Riskpilot
← Back to search
Sign in
Sign in
Get full access
Alex Therapeutics AB
AB
Active
Org 5591508642
Kungsgatan 64, 111 22
Stockholm
Computer programming activities
·
NACE 6210
Est. 2018 · 8 years old
1-4 employees
Monitor
Share
Sweden
/
Companies
/
Computer programming activities
/
Alex Therapeutics AB
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Revenue
SEK millions
10M
7M
5M
2M
0M
2021: 7M
7M
2021
2022: 8M (+14% vs 2021)
8M
+14%
2022
2023: 3M (-62% vs 2022)
3M
-62%
2023
2024: 3M (0% vs 2023)
3M
0%
2024
2025: 0M (-100% vs 2024)
0M
-100%
2025
EBITDA
SEK millions
7M
0M
-8M
-15M
-22M
2021: 1M
1M
2021
2022: 0M (-100% vs 2021)
0M
-100%
2022
2023: -15M
-15M
2023
2024: -16M (-7% vs 2023)
-16M
-7%
2024
2025: -15M (+6% vs 2024)
-15M
+6%
2025
Income statement
SEK thousands
Item
2025
2024
2023
2022
2021
Revenue
261
2 716
2 962
8 192
6 636
Staff expenses
−9 200
—
—
—
—
EBITDA
−14 747
−15 622
−14 505
168
996
Depreciation & amort.
−1 093
−5 215
−108
−65
−5
EBIT
−15 840
−20 837
−14 613
103
991
Net financials
64
790
990
−61
3
Profit before tax
−15 775
−20 047
−13 624
42
994
Tax
—
−5
−13
−37
−0
Net profit
−15 775
−20 052
−13 637
5
994
Balance sheet
SEK thousands
Item
2025
2024
2023
2022
2021
Total assets
11 899
27 924
47 646
28 619
12 658
Equity
10 958
26 479
45 995
26 258
8 146
Long-term debt
—
0
0
0
0
Short-term debt
941
1 446
1 651
2 361
4 513
Total debt
941
1 446
1 651
2 361
4 513
Financial ratios
5-year trend
EBITDA margin
<−999 %
This company
15,8 %
Market median
This company
Market median
>999% below market
2021
2025
Equity ratio
92,1 %
This company
38,2 %
Market median
This company
Market median
141% above market
2021
2025
Return on equity
−144,0 %
This company
18,4 %
Market median
This company
Market median
883% below market
2021
2025
Net profit margin
<−999 %
This company
8,1 %
Market median
This company
Market median
>999% below market
2021
2025
Asset turnover
0,02×
This company
1,12×
Market median
This company
Market median
98% below market
2021
2025
Debt / equity
0,09×
This company
0,62×
Market median
This company
Market median
85% below market
2021
2025
Annual reports & filings
Annual report 2025
Filed via Bolagsverket / SCB · Period 2025-01-01 – 2025-12-31
View
PDF
Annual report 2024
Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
View
PDF
Annual report 2022
Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
View
PDF
Annual report 2021
Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
View
PDF
More on Alex Therapeutics AB
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
